Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte

  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités

1 result

  • Active substance : fer
  • Active substance : leucine
  • Active substance : sulfasalazine
  • Topics : Bone marrow diseases
  • Topics : Blood and lymphatic diseases
Filter
Topic
  • Diseases and conditions (1)
  • Plus ...
    • Congenital, genetic and rare diseases (1)
    • Blood and lymphatic diseases (1)
    • Plus ...
      • Bone marrow diseases (1)
      • Anemia and hemoglobinopathies (1)
Content type
  • Practice Guidelines and Other Guides (1)
  • Plus ...
    • Chronic disease guide (1)
Date
  • Last five years (1)
Langue
  • Français (1)
Substance active
  • aciclovir (1)
  • alcool (1)
  • alemtuzumab (1)
  • allopurinol (1)
  • amoxicilline (1)
  • atovaquone (1)
  • azathioprine (1)
  • busulfan (1)
  • carbimazole (1)
  • chloroquine (1)
  • chlorpropamide (1)
  • ciclosporine (1)
  • ciprofloxacine (1)
  • cyclophosphamide (1)
  • danazol (1)
  • eltrombopag (1)
  • fer (1)
  • itraconazole (1)
  • leucine (1)
  • piroxicam (1)
  • posaconazole (1)
  • prednisolone (1)
  • rifampicine (1)
  • rituximab (1)
  • romiplostim (1)
  • sirolimus (1)
  • sulfasalazine (1)
  • tacrolimus (1)
  • valaciclovir (1)
  • voriconazole (1)
More filter Other Filter Icon
Search Export

Practice guidelines and other guides - 1 result

  • Acquired and inherited aplastic anemia

    Chronic disease guide - Posted on 4/5/2024
    Download guide
    Add to my selection

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
ftJsT5853ed9QQkR